Diluted EPS came in at $-2.60, missed the $-0.03 consensus by $2.56.
Trailing eight quarters through Q4 2024
Common questions about Tevogen Bio Holdings, Inc.'s Q4 2024 earnings report.
Tevogen Bio Holdings, Inc. (TVGN) reported Q4 2024 earnings on April 2, 2025.
Tevogen Bio Holdings, Inc. reported diluted EPS of $-2.60 for Q4 2024.
EPS missed the consensus estimate of $-0.03 by $2.56.
You can read the 10-K periodic report (0001641172-25-002426) directly on SEC EDGAR. The filing index links above go to sec.gov.